Tissue Repair (ASX:TRP) Marketable Securities: A$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:TRP Tissue Repair Ltd ASX:TRP
22 GF Score
Price A$0.11
View Full Analysis

What is Tissue Repair Marketable Securities?

Tissue Repair ASX:TRP 22 Marketable Securities is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:TRP with a GF Score™ of 22/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Tissue Repair's Marketable Securities for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Tissue Repair  (ASX:TRP) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Tissue Repair Marketable Securities Related Terms

Tissue Repair Marketable Securities Historical Data

* Premium members only.

The historical data trend for Tissue Repair's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Repair Marketable Securities Chart

Tissue Repair Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Marketable Securities
0.00 0.00 0.00 0.00 0.00

Tissue Repair Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:TRP
22GF Score
Tissue Repair Ltd ASX:TRP
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tissue Repair Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of A$0.00 Mil mean?
Tissue Repair (ASX:TRP) has a Marketable Securities of A$0.00 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Tissue Repair and its competitors.
Is Tissue Repair's Marketable Securities too high?
Tissue Repair's current Marketable Securities is A$0.00 Mil. Overall, Tissue Repair has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Tissue Repair's Marketable Securities compare to VRTX and REGN?
Tissue Repair's Marketable Securities of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Tissue Repair and its competitors. Tissue Repair's current Marketable Securities is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Repair stock overvalued right now?
Tissue Repair (ASX:TRP) has a current Marketable Securities of A$0.00 Mil. The current Marketable Securities is A$0.00 Mil. Tissue Repair's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Tissue Repair (ASX:TRP), the current Marketable Securities is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tissue Repair Business Description

Address 821 Pacific Highway, Tower A, Level 9, The Zenith, Chatswood, NSW, AUS, 2067
Tissue Repair Ltd is a clinical-stage biopharmaceutical company engaged in development of wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.
22GF Score

Get the complete analysis for ASX:TRP

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.11
Price